EmerWell Liposomal at SupplySide West 2026, Booth 7751

EmerWell Bio LLC, the U.S. subsidiary of Wellgreen Technology, will exhibit at SupplySide West 2026 in Booth 7751 at Mandalay Bay, Las Vegas, from 28 to 30 October 2026, presenting the EncapsWell™ liposomal platform and a working view of how its liposomal powders are engineered, characterized, and supplied from San Diego. U.S. and international brands can meet the company's formulation scientists at the booth and review particle data on the ingredients they are considering.

For formulators, the invitation is direct: bring the active ingredient that is underperforming in your current format, and review the encapsulation route with the team that would build it.

Event details

Show	SupplySide West 2026
Dates	28–30 October 2026
Venue	Mandalay Bay Convention Center, Las Vegas, NV, USA
Booth	7751
Team on site	EmerWell Bio LLC (U.S.) + Wellgreen R&D and commercial teams

The Liposomal Powders on Display

Product	Stated platform benefit
Liposomal Curcumin	4–6× bioavailability improvement over conventional curcumin
Liposomal Quercetin	Solubility and absorption enhanced
Liposomal Resveratrol	Superior stability against degradation
Liposomal Omega-3 Powder	Odorless, oxidation-resistant powder format
Liposomal Glutathione	3–5× cellular delivery, enzyme protected
Liposomal NAD	Stable, membrane-permeable format for anti-aging formulations

All grades are produced under cGMP conditions and are available for OEM/ODM customization, including customer-specified actives beyond the standard catalog.

What Separates a Liposomal Powder from a Marketing Claim

Most formulations labeled "liposomal" fail on three measurable points, and all three are checkable at the booth.

1. Encapsulation architecture. The active must sit inside a phospholipid bilayer — not merely be blended with phospholipids. That distinction determines whether the ingredient behaves differently in the body at all.

2. Particle size and polydispersity. EncapsWell™ materials are engineered to a particle size below 400 nm with a polydispersity index (PDI) below 0.5. Particle size governs absorption behavior; PDI governs consistency. A batch that averages 300 nm with wide spread is a different product from one that averages 300 nm tightly distributed.

3. Batch-to-batch reproducibility. A formulation that performs in a pilot run and drifts at commercial scale is an expensive lesson. Reproducibility is the parameter that decides whether a liposomal claim survives a year of production — and it is the parameter most often missing from supplier conversations.

EmerWell verifies these properties with dynamic light scattering (DLS) and transmission electron microscopy (TEM), and the characterization data for the displayed products — including liposomal glutathione and liposomal omega-3 powder — will be available for review at Booth 7751.

Developed and Characterized in Our Own San Diego Laboratory

EmerWell's differentiation is geographic as much as technical. The company operates an independent laboratory and warehouse in San Diego, California — address: 6342 Ferris Square, San Diego, CA 92121 — staffed by a research team of three PhDs and master's-level scientists covering the full chain of liposome development, from particle engineering through production.

For North American brands, that translates into practical operating advantages:

Formulation consultation in your time zone. Technical questions do not have to survive an overnight delay.

Faster sample turnaround, with samples dispatched from the U.S. rather than from overseas.

Shorter lead times for U.S. and Canadian customers drawing on domestic warehouse stock.

Direct access to the scientists who designed the formulation, not a relayed account of it.

The San Diego team will be at Booth 7751 for all three show days, and discussions started at the booth can continue directly with the same people after the event.

Custom Formulation: From Concept to Production Scale-Up

Off-the-shelf liposomal actives solve a defined set of problems. The more common request is a specific one: an active that is poorly water-soluble, unstable in powder blends, bitter, or simply not absorbed well enough to justify its label position.

EmerWell takes those projects through concept, formulation design, particle engineering, stability assessment, and production scale-up as a single engagement. Because the same organization covers R&D and manufacturing, specifications that pass in development are transferred into production without an external handoff.

For brands evaluating the EncapsWell™ route, the most useful first step is a technical discussion rather than a quotation: which active, what dose, what delivery format, and what failure mode is being fixed.

Why Liposomal Delivery Keeps Outgrowing the Category

Liposomal formats have moved from a premium niche to a standard option in supplement development. Research and Markets values the liposomal and lipid nanoparticle delivery systems market at USD 6.70 billion in 2025, growing at a 10.23% CAGR — a growth rate that reflects a structural problem the format solves: natural actives are often poorly bioavailable in conventional powder and capsule formats.

That same pressure is visible upstream. Botanical extract demand continues to expand, with Technavio projecting USD 23.47 billion of growth between 2025 and 2030 at a 10.2% CAGR. As more brands formulate with high-value plant actives, delivery performance becomes the limiting factor on what a label claim can honestly promise — which is the problem EmerWell was built to address.

Meet the Liposomal Team at Booth 7751

Bring one of these to the booth and the conversation can go straight to technical depth:

The active ingredient and target dose per serving

The current format that is underperforming (capsule, powder blend, gummy, beverage)

Target particle size or existing specification requirements

Intended volumes and launch timeline

Label claims being considered, so feasibility can be assessed honestly

Meetings can be arranged in advance via info@emerwell-bio.com or +1 619 877 5461.

Booth: 7751 · Dates: 28–30 October 2026 · Venue: Mandalay Bay Convention Center, Las Vegas, NV

FAQ

Where is EmerWell Bio exhibiting at SupplySide West 2026? Booth 7751 at the Mandalay Bay Convention Center, Las Vegas, from 28 to 30 October 2026.

What does EncapsWell™ refer to? It is EmerWell's liposomal delivery platform. Actives are encapsulated within a phospholipid bilayer, with particle size engineered below 400 nm and PDI below 0.5, verified by DLS and TEM and supported by batch-to-batch reproducibility data.

Which liposomal ingredients will be shown at the booth? Liposomal curcumin, quercetin, resveratrol, omega-3 powder, glutathione, and NAD, along with additional catalog grades such as liposomal NMN, vitamin C, vitamin D3, and B12.

Is EmerWell a U.S.-based operation? Yes. EmerWell Bio LLC is based in San Diego, California, where the company operates its own laboratory and warehouse with a research team of three PhDs and master's-level scientists.

Can you develop a liposomal version of a custom active? Yes. Custom formulation work covers concept development, particle engineering, stability assessment, and production scale-up, with OEM/ODM supply available.

How quickly can U.S. customers receive samples? Because samples ship from the San Diego facility, U.S. and Canadian turnaround is measured in days rather than weeks compared with overseas dispatch.

How do I book a technical meeting at the show? Email info@emerwell-bio.com or call +1 619 877 5461, and indicate the active ingredient and dosage form you are working with.

About EmerWell Bio LLC

EmerWell Bio LLC is a San Diego–based supplier of liposomal delivery technologies for the nutraceutical, functional food, and personal care industries, and the U.S. subsidiary of Wellgreen Technology Co., Ltd. Through the proprietary EncapsWell™ platform, the company provides liposomal ingredient supply and end-to-end formulation services — from R&D design through large-scale OEM production — supported by an independent laboratory, warehouse, and a research team of three PhDs and master's-level scientists at 6342 Ferris Square, San Diego, CA 92121.

Contact: info@emerwell-bio.com · +1 619 877 5461

LinkedIn: linkedin.com/company/emerwell

References

Research and Markets. Liposomal & Lipid Nanoparticle Drug Delivery Systems Market — USD 6.70 billion in 2025, 10.23% CAGR. https://www.researchandmarkets.com/reports/6127769/liposomal-and-lipid-nanoparticle-drug-delivery
Technavio. Botanical Extracts Market Analysis — growth of USD 23.47 billion at 10.2% CAGR, 2025–2030. https://www.technavio.com/report/botanical-extracts-market-industry-analysis
American Herbal Products Association (AHPA). SupplySide Global 2026 event listing (the 2026 edition of SupplySide West) — Mandalay Bay, 28–30 October 2026. https://www.ahpa.org/ev_calendar_day.asp?date=10/28/26&eventid=334